Effect of Shilajit Rasayana compound in Diabetic Nerve Damage
Phase 2
Completed
- Conditions
- Health Condition 1: null- Diabetic Distal Symmetric Poly Neuropathy
- Registration Number
- CTRI/2012/06/002712
- Lead Sponsor
- Institute for Post Graduate Teaching Research in Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Metabolically stable Type 2 diabetic patients with symptomatic diabetic sensorimotorpolyneuropathy (DSPN)
Patients of either sex between the age group 18â??80 years
Exclusion Criteria
1.Patients with other metabolic and endocrinal disorders.
2.Patients with non-diabetic neuropathies
3.Patients suffering from infectious diseases.
4.Patients with non-healing ulcer/ulcers.
5.Patients with Disabling Diabetic Polyneuropathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Agnibala, Rogabala, and Chetasbala,Quality Of Life(WHO QoL) â?? BREF20, Biothesiometer for quantitative vibration assessment, Michigan Neuropathy Screening Instrument score (MNSI)and Modified Toronto Clinical Neuropathy ScoreTimepoint: 12 weeks (90)
- Secondary Outcome Measures
Name Time Method HBA1cTimepoint: 90days